- Editorial
Molecular Diagnosis and Novel Therapies for Neuromuscular Diseases
- Rika Maruyama and
- Toshifumi Yokota
With the development of novel targeted therapies, including exon skipping/inclusion and gene replacement therapy, the field of neuromuscular diseases has drastically changed in the last several years. Until 2016, there had been no FDA-approved drugs...

